Floatz logo

Pevonedistat

Myeloid Neoplasm

M.D. Anderson Cancer CenterPhase 1/2Active
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
89/ 100

Competitive context

29 Active assets in the Myeloid Neoplasm cohort.

Asset / SponsorPhaseRating
Mitoxantrone
First Affiliated Hospital of Zhejiang University
Phase 3BBB
Cytosin-Arabinosid
First Affiliated Hospital of Zhejiang University
Phase 3BBB
Cladribine
University of Washington
Phase 2BBB
Cyclophosphamide
Prelude Therapeutics
Phase 3BB
Recombinant Human Granulocyte Colony-Stimulating Factor
University of Washington
Phase 2BB

View all 49 →

Same molecule, other indications

Pevonedistat is also rated in:

chronic myelomonocytic leukemiaDormant
BB
Indicative ·
70 / 100
View asset →
acute myeloid leukemiaDormant
BB
Indicative ·
66 / 100
View asset →
myelodysplastic syndromeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →